Norway vs Switzerland: Cause of death, by non-communicable diseases, ages 15-59
Norway
75.6%
in 2021
Switzerland
75.1%
in 2021
Norway rank
22nd
Switzerland rank
23rd
Cause of death, by non-communicable diseases, ages 15-59 over time
- Norway
- Switzerland
How they compare
Norway currently reports 75.6% against 75.1% in Switzerland, a difference of 0.5%.
The two have swapped places 2 times across 6 shared years of data; in 2000 it was Norway ahead.
Norway ranks 22nd and Switzerland ranks 23rd of 185 countries.
Norway has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Norway | Switzerland | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 78.8% | 73.5% | 5.3% | Norway |
| 2010s | 78.7% | 78.6% | 0.1% | Norway |
| 2020s | 76.6% | 75.8% | 0.9% | Norway |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 15-59, Norway or Switzerland?
- Norway, at 75.6% against 75.1% in Switzerland as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 15-59 between Norway and Switzerland?
- 0.5%, with Norway ahead.
- How many years of comparable data are there for Norway and Switzerland?
- 6 years are reported by both, from 2000 to 2021.
- How do Norway and Switzerland rank globally for cause of death, by non-communicable diseases, ages 15-59?
- Norway ranks 22nd and Switzerland ranks 23rd of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 15-59 (% of total deaths ages 15-59). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths ages 15-59 due to non-communicable diseases divided by number of all deaths ages 15-59 expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.